Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
US Stock MarketDetailed Quotes
Neurocrine Biosciences (NBIX)
- 128.890
- -2.750-2.09%
Close Apr 10 16:00 ET
- 128.890
- 0.0000.00%
Post 16:10 ET
12.94BMarket Cap27.60P/E (TTM)
133.000High127.170Low806.99KVolume132.020Open131.640Prev Close104.18MTurnover0.82%Turnover Ratio27.60P/E (Static)100.36MShares160.18052wk High3.98P/B12.77BFloat Cap92.31052wk Low--Dividend TTM99.07MShs Float160.180Historical High--Div Yield TTM4.43%Range %1.940Historical Low129.095Avg Price1Lot Size
Neurocrine Biosciences (NBIX) Key Financial Indicators
NBIX Earnings per Share (EPS)
According to the latest financial report of Neurocrine Biosciences, the latest earnings per share (TTM) for the company is 1.48. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
NBIX Free Cash Flow (FCF)
Interested in knowing about Neurocrine Biosciences's free cash flow? The latest report shows it as 390.80M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
NBIX Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Neurocrine Biosciences shows that the company's current ratio is 3.39, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
NBIX Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Neurocrine Biosciences, the quick ratio is 2.92, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
NBIX Return on Equity (ROE)
Want to learn more about the financial health of Neurocrine Biosciences? The latest ROE figure is 4.91%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
NBIX Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Neurocrine Biosciences, the total asset return on investment (ROA) is 3.45%.
Currency: USD
Quarterly
Loading...
NBIX Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Neurocrine Biosciences's latest financial report to see how their gross margin is doing - currently at 97.82%.
Currency: USD
Quarterly
Loading...
NBIX Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Neurocrine Biosciences, the net profit margin is 19.08%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Following the collapse of peace talks between the US and Iran, the US Central Command announced a full blockade of all vessels entering and
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm